DataExpo GAKG DeepReport Navigation

Copyright©2015-2024 Acemap, Inc. Shanghai Jiao Tong University. All rights reserved.

沪ICP备18028330号

AK

A. Kuglstatter

Roche (Switzerland)

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

M. Stihle

Roche (Switzerland)

Armando G. Villaseñor

California State Polytechnic University

J. Benz

Universitätsklinikum Erlangen

David W. Banner

Roche (Switzerland)

M. Ghate

La Roche College

Jörg Benz

Roche (Switzerland)

A. Shao

Roche (United States)

David Goldstein

University of California, Los Angeles

Maude Giroud

Helmholtz Zentrum München

G. Fritzsch

Max Planck Institute of Biophysics

Cooperative Institutions

Roche (Switzerland)

La Roche College

Roche (United States)

ETH Zurich

Roche Pharma AG (Germany)

Centre National de la Recherche Scientifique

The King's College

Stanford University

University of California, San Francisco

Max Planck Society

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Crystal structure of spleen tyrosine kinase complexed with [6-((S)-2-Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-imidazo[1,2-b]pyridazin-8-yl)-amine

A. Kuglstatter Martin J. Slade

Crystal (programming language)

10.2210/pdb4fz6/pdb

Cite

Citations (0)

JAK3 kinase domain in complex with 1-[(3S)-1-isobutylsulfonyl-3-piperidyl]-3-(5H-pyrrolo[2,3-b]pyrazin-2-yl)urea

A. Kuglstatter A. Shao

10.2210/pdb4qt1/pdb

Cite

Citations (0)

CATHEPSIN L IN COMPLEX WITH (3S,14E)-8-(azetidin-3-yl)-19-chloro-N-(1-cyanocyclopropyl)-5-oxo-12,17-dioxa-4-azatricyclo[16.2.2.06,11]docosa-1(21),6,8,10,14,18(22),19-heptaene-3-carboxamide

A. Kuglstatter M. Stihle

10.2210/pdb6f06/pdb

Cite

Citations (0)

Crystal structure of BTK kinase domain complexed with 1-[5-[3-(7-tert-butyl-4-oxo-quinazolin-3-yl)-2-methyl-phenyl]-1-methyl-2-oxo-3-pyridyl]-3-methyl-urea

A. Kuglstatter A. Wong

10.2210/pdb4otq/pdb

Cite

Citations (0)

Crystal structure of BTK kinase domain complexed with 6-cyclopropyl-2-[3-[5-[[5-(4-ethylpiperazin-1-yl)-2-pyridyl]amino]-1-methyl-6-oxo-3-pyridyl]-2-(hydroxymethyl)phenyl]-8-fluoro-isoquinolin-1-one

A. Kuglstatter Andrew Wong

Hydroxymethyl

10.2210/pdb4otr/pdb

Cite

Citations (0)

Crystal structure of spleen tyrosine kinase complexed with a 2-substituted 7-azaindole

A. Kuglstatter Armando G. Villaseñor

Crystal (programming language)

10.2210/pdb3fqh/pdb

Cite

Citations (0)

Crystal structure of IRAK4 kinase domain complexed with AMPPNP

A. Kuglstatter Armando G. Villaseñor Michelle F. Browner

10.2210/pdb2oid/pdb

Cite

Citations (0)

CATHEPSIN L IN COMPLEX WITH (3S,14E)-19-chloro-N-(1-cyanocyclopropyl)-5-oxo-12,17-dioxa-4-azatricyclo[16.2.2.06,11]docosa-1(21),6(11),7,9,14,18(22),19-heptaene-3-carboxamide

David W. Banner J. Benz A. Kuglstatter

10.2210/pdb6ezp/pdb

Cite

Citations (0)

The Structure of Reaction Centers from Purple Bacteria

Kluwer Academic Publishers eBooks (2006)

G. Fritzsch A. Kuglstatter

Rhodobacter sphaeroides

Purple bacteria

10.1007/0-306-48209-6_6

Cite

Citations (1)

A potent seven-membered cyclic BTK (Bruton's tyrosine Kinase) chiral inhibitor conceived by structure-based drug design to lock its bioactive conformation

Bioorganic & Medicinal Chemistry Letters (2019)

Francisco Lopez‐Tapia Yan Lou Christine Brotherton‐Pleiss A. Kuglstatter Sung‐Sau So

10.1016/j.bmcl.2019.03.001

Cite

Citations (10)

More pages